Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI)
2016 (English)In: Neuropharmacology, ISSN 0028-3908, E-ISSN 1873-7064, Vol. 101, 506-518 p.Article in journal (Refereed) PublishedText
Traumatic brain injury (TBI) is often a result of traffic accidents, contact sports or battlefield explosions. A mild form of traumatic brain injury (mTBI) is frequently underestimated, as the immediate physical symptoms decrease rapidly and conventional neuroimaging studies often do not show visible evidence of brain lesions. However, cognitive impairments persist for weeks, months or even years after the incident. Endogenous opioids were documented to play a role in thmodulation of mTBI pathology, whereas exogenous opioids were shown to possess neuroprotective properties. In the present study, biphalin, a dimeric enkephalin analog, improved cognitive performance in the Morris Water Maze and Novel Object Recognition tests in a mouse weight-drop model of mTBI. The effect of a single systemic injection of 10 mg/kg biphalin immediately after trauma was reversed by naltrexone, suggesting an opioid receptor-mediated mechanism. Biphalin also reduced cortical and hippocampal neurodegeneration, as shown by silver staining. Our data indicates that opioid receptor activation by biphalin may provide neuroprotection of post-traumatic neurodegeneration processes and may protect against memory impairments.
Place, publisher, year, edition, pages
2016. Vol. 101, 506-518 p.
Neuroprotection, Biphalin, Traumatic brain injury, Mouse model
Neurology Pharmaceutical Sciences
IdentifiersURN: urn:nbn:se:uu:diva-274898DOI: 10.1016/j.neuropharm.2015.10.014ISI: 000367483800047OAI: oai:DiVA.org:uu-274898DiVA: diva2:899866